Advarra purchases IntegReview IRB
The institutional review board services provider has acquired the AAHRPP-accredited central IRB, which specializes in early-phase research.
The institutional review board services provider has acquired the AAHRPP-accredited central IRB, which specializes in early-phase research.
The two companies have joined forces to collaborate on the commercial launch of Gimoti, a nasal spray for patients suffering from diabetic gastroparesis.
Preliminary results from a recent clinical trial indicate the drug touted by US leaders as a possible treatment offers no significant benefit to patients.